Stock Screener App

무료 -

설치하다

10.66

0.00% 0.00

after-market

시간 외 거래: 10.66

Drugs Made In America Acquisition Corp (DMAA)

개요 뉴스 가격 이력 토론 예측

Drugs Made In America Acquisition Corp 주식(DMAA)의 최신 뉴스

Enterprise value to EBITDA forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAU - TradingView

Price to book forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAU - TradingView

OACCU Stock Fund Price and Chart — NASDAQ:OACCU - TradingView

Price to sales forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAR - TradingView

Pfizer Inc. - Encyclopedia Britannica

NTWO PE Ratio & Valuation, Is NTWO Overvalued - Intellectia AI

Drugs Made In America Acquisition Corp. (DMAA) Holds Steady Near Support as SPAC Sector WatchesHedge Fund Exposure - dars.gov.et

DMAADrugs Made In America Acquisition Corp Volatility & Greeks - Finviz

DMII Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Price to book forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView

Price to sales forward of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView

Feis Equities and Lawrence Feis disclose 5.08% ownership in DMAA (DMAA) - Stock Titan

Price to sales forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAU - TradingView

Price to sales forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView

Enterprise value to revenue forward of Drugs Made In America Acquisition Corp. – BOATS:DMAAR - TradingView

Drugs Made In America Acquisition II Units (DMIIU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

QLEP Stock Price and Chart — NYSE:QLEP - TradingView

Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 - TradingKey

Drugs Made In America Acquisition Corp. (DMAA) Holds Steady Near Resistance as SPAC Sentiment Remains CautiousHedge Fund Exposure - dars.gov.et

Number of shareholders of Drugs Made In America Acquisition II Corp. – NASDAQ:DMIIU - TradingView

Drugs Made In America Acquisition II Corp. Rights (DMIIR) Holds Flat at $0.10 Amid Low ActivityGrowth Factor - dars.gov.et

Drugs Made In America Acquisition Corp (DMAAU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

PLMK Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Drugs Made In America Acquisition Corp (DMAAR) Valuation: PE, PB & Fair Value Analysis - TradingKey

Drugs Made In America Acquisition Corp (DMAAR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Drugs Made In America Acquisition Corp (DMAAR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Drugs Made In America Acquisition Corp (DMAAU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Drugs Made In America Acquisition Corp (DMAAU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Drugs Made In America Acquisition Corp (DMAAU) Valuation: PE, PB & Fair Value Analysis - TradingKey

Drugs Made In America Acquisition Corp (DMAAU) Institutional Confidence - TradingKey

Drugs Made In America Acquisition Corp (DMAAR) Institutional Confidence - TradingKey

Drugs Made In America Acquisition Corp - TradingKey

Drugs Made In America Acquisition Corp (DMAA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Drugs Made In America Acquisition Corp (DMAAR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Drugs Made In America Acquisition Corp (DMAA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Drugs Made In America Acquisition Corp (DMAA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Drugs Made In America Acquisition Corp (DMAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR) Institutional Confidence - TradingKey

Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 (DMIIR) Valuation: PE, PB & Fair Value Analysis - TradingKey

Drugs Made In America Acquisition II Ord Shs (DMII) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Drugs Made In America Acquisition II Ord Shs (DMII) Institutional Confidence - TradingKey

Drugs Made In America Acquisition II Ord Shs (DMII) Valuation: PE, PB & Fair Value Analysis - TradingKey

Drugs Made In America Acquisition Corp (DMAA) Valuation: PE, PB & Fair Value Analysis - TradingKey

Drugs Made In America Acquisition II Ord Shs (DMII) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Drugs Made In America Acquisition Corp (DMAA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Drugs Made In America Acquisition II Units - TradingKey

Drugs Made In America Acquisition II Units (DMIIU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Drugs Made In America Acquisition II Units (DMIIU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Drugs Made In America Acquisition II Ord Shs (DMII) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Drugs Made In America Acquisition II Ord Shs (DMII) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Drugs Made In America Acquisition II Ord Shs - TradingKey

Drugs Made In America Acquisition II Units (DMIIU) Valuation: PE, PB & Fair Value Analysis - TradingKey

Drugs Made In America Acquisition II Units (DMIIU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Drugs Made In America Acquisition Corp (DMAAU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Drugs Made In America Acquisition Corp (DMAAU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Drugs Made In America Acquisition Corp (DMAAR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Drugs Made In America Acquisition Corp (DMAAR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

DMAA Holds Near $10.62 as Support and Resistance Levels TightenDouble Top - newsline.com

DMAAR Rights Trade Flat Near All-Time Low as Investors Await Merger CatalystBearish Pattern Stocks - newsline.com

DMAA Hovers Near $10.62 as SPAC Consolidates Ahead of Potential CatalystFair Value Gap - newsline.com

US Retreat from Global Leadership Stirs Uncertainty Across AsiaFinancial Health Score - newsline.com

DMAAR Rights Hold Steady at $0.10: Analyzing the Stalemate for Drugs Made In America Acquisition Corp.Channel Breakout - newsline.com

Drugs Made In America Acquisition II Corp. Right (DMIIR) Holds Flat at $0.08 as Rights Trading Remains DormantDip Buy Trade - newsline.com

DMII Holds Steady at $10.08: SPAC Trading in a Narrow RangeTICK Divergence - newsline.com

DMIIU Holds Steady at $10.12 as SPAC Unit Trades in Tight RangeFear Greed Extreme - newsline.com

Drugs Made In America Acquisition II Corp. (DMII) Holds Steady at $10.08 – Quiet Trading Reflects Pre-Merger StasisETF AUM Growth - dars.gov.et

DMIIR Rights Trading Slumps 9.09% to $0.08 – Micro-Cap Struggles for DirectionReversal Setup Alerts - newsline.com

AEXA

$11.82

0.17%

CXII

$10.70

0.65%

EVAC

$10.17

0.20%

CEPF

$10.43

0.10%

BCSS

$10.26

0.00%

DMII

$10.10

0.05%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개